Noel W. Clarke
University of Salford
CancerInternal medicineUrologySurgeryPathologyOncologyRandomized controlled trialChemistryProstateAndrogen deprivation therapyMetastasisDiseaseProstate cancerBladder cancerDocetaxelGynecologyCancer researchRadiation therapyMedicineBiology
437Publications
72H-index
12.5kCitations
Publications 449
Newest
#1H. Rush (UCL: University College London)H-Index: 6
#2Laura Murphy (UCL: University College London)H-Index: 2
Last. Ruth E Langley (UCL: University College London)H-Index: 28
view all 37 authors...
PURPOSEDocetaxel and abiraterone acetate plus prednisone or prednisolone (AAP) both improve survival when commenced alongside standard of care (SOC) androgen deprivation therapy in locally advanced...
Source
Background: The relative cardiovascular safety of gonadotropin-releasing hormone (GnRH) antagonists compared with GnRH agonists in men with prostate cancer and known atherosclerotic cardiovascular ...
Source
#1Julie Nossiter (Lond: University of London)H-Index: 8
#2Melanie Morris (Lond: University of London)H-Index: 9
Last. Paul Cathcart (Guy's and St Thomas' NHS Foundation Trust)H-Index: 13
view all 10 authors...
Improvements in short-term outcomes have been reported for hospitals with higher radical prostatectomy (RP) volumes. However, the association with longer-term functional outcomes is unknown. All patients diagnosed with non-metastatic prostate cancer in the English NHS between 2014 and 2016 who underwent RP (N = 10,089) were mailed a survey ≥18 months after diagnosis. Differences in patient-reported urinary continence and sexual function (EPIC-26 on scale from 0 to 100) by hospital volume group (...
Source
#1Matthew G. Parry (Lond: University of London)H-Index: 8
#2Jemma Boyle (Lond: University of London)H-Index: 2
Last. Heather Payne (UCL: University College London)H-Index: 11
view all 11 authors...
Many factors are implicated in the potential ‘under-treatment’ of prostate cancer but little is known about the between-hospital variation. The National Prostate Cancer Audit (NPCA) database was used to identify high-risk localised or locally advanced prostate cancer patients in England, between January 2014 and December 2017, and the treatments received. Hospital-level variation in radical local treatment was explored visually using funnel plots. The intra-class correlation coefficient (ICC) qu...
Source
#4Laura Murphy (UCL: University College London)H-Index: 2
Source
#2Luca AfferiH-Index: 6
Last. David NicolH-Index: 21
view all 24 authors...
Source
#1Matthew G. ParryH-Index: 8
#2Julie NossiterH-Index: 8
Last. Noel W. ClarkeH-Index: 72
view all 11 authors...
INTRODUCTION AND OBJECTIVE:No direct comparison has been made between England and the US with respect to the diagnosis and treatment of men with prostate cancer over one contemporary time period. W...
Source
#2Allaudin IssaH-Index: 3
Last. Noel W. Clarke (Salford Royal NHS Foundation Trust)H-Index: 72
view all 10 authors...
Source
BACKGROUND AND PURPOSE Hemiscrotectomy with en bloc orchidectomy represents a radical primary, completion, or salvage option in men with inguinoscrotal cancers. We describe our surgical technique and peri-operative and oncological outcomes. PATIENTS AND METHODS Retrospective cohort study of 16 men treated at a supra-regional referral centre with open radical hemiscrotectomy with or without en bloc orchidectomy between 2010 and 2020. Peri-operative and survival outcomes were analysed. RESULTS Rad...
Source
#1Gerhardt Attard (UCL: University College London)H-Index: 77
#2Louise Brown (UCL: University College London)H-Index: 21
Last. Nicholas D. James (The Royal Marsden NHS Foundation Trust)H-Index: 68
view all 5 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.